The global life science company Bayer has announced a $2.2 billion investment in Ohio, adding to the over $11 trillion in investments the U.S. has seen during President Donald Trump’s second term in office.
\n\nA press release details the investment as a “central element” of Bayer’s growth strategy with this phase specifically involving a pharmaceutical manufacturing site in New Albany.
\n\nBayer CEO Bill Anderson said in a statement that the company has viewed the U.S as a “key manufacturing base and innovation hub.”
\n\nHe continued, “This landmark investment underscores our commitment. The new site will be home to manufacturing expertise and a skilled workforce that will strengthen our ability to deliver innovative, high-quality medicines to patients both in the United States and abroad.”
\n\nOverall, the project is expected to provide an estimated 1,500 construction jobs and as many as 600 “high-value jobs” thereafter.
\n\n“The facility will be a strong strategic addition to our global Product Supply network. As we continue to invest in our existing manufacturing sites around the globe, our planned presence in Ohio will further enhance our ability to serve our markets with greater resilience and reliability,” Holger Weintritt, Head of Product Supply at Bayer’s Pharmaceuticals division, said…
Original source: https://www.breitbart.com/economy/
